Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis. [electronic resource]
Producer: 20110614Description: 567-574 p. digitalISSN:- 1569-8041
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- economics
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cetuximab
- Cisplatin -- administration & dosage
- Cost-Benefit Analysis
- Humans
- Lung Neoplasms -- drug therapy
- Markov Chains
- Monte Carlo Method
- Neoplasm Staging
- Proportional Hazards Models
- Sensitivity and Specificity
- Survival Analysis
- Treatment Failure
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.